Funding

International Agency for Research on Cancer

The International Agency for Research on Cancer (IARC) is an intergovernmental agency that forms part of the World Health Organization of the United Nations.

IARC’s mission is ‘cancer research for cancer prevention’ and it has six research objectives, to:

  • describe the occurrence of cancer
  • understand the causes of cancer
  • evaluate and implement cancer prevention and control strategies
  • increase the capacity for cancer research
  • provide strategic leadership and enhance the impact of the Agency′s contribution to global cancer research
  • enable and support the efficient conduct and coordination of research.

IARC governance

IARC's general policy is directed by a governing council, composed of the representatives of participating states and of the Director-General of the World Health Organization. The Medical Research Council represents the United Kingdom of Great Britain and Northern Ireland through the governing council.

Cancer research

IARC promotes international collaboration and interdisciplinarity in cancer research. By bringing together skills in epidemiology, laboratory sciences and biostatistics, the Agency aims to identify the causes of cancer so that preventive measures may be adopted and the burden of disease and associated suffering reduced.

A significant feature of the IARC is its expertise in coordinating research across countries and organisations; this is facilitated by its independent role as an international organisation. One of the products of IARC's coordinating role is an increasingly important biobank, which currently contains more than 10 million well-characterised samples from 1 million subjects from around the world.

Training opportunities

The IARC funds cancer research through a variety of schemes, including various fellowship schemes such as:

  • Postdoctoral Fellowships
    • Fellowships are tenable at the IARC in Lyon, France working in a research group and applicants from any country are eligible.
    • Disciplines covered are: epidemiology (including genetic and molecular), biostatistics, bioinformatics, and areas related to mechanisms of carcinogenesis including molecular and cell biology, molecular genetics, epigenetics, and molecular pathology.
    • Candidates are required to have finished their doctoral degree (PhD) within five years of the closing date for application, or be in the final phase of completing their doctoral degree.
  • Expertise Transfer Fellowship
    • The IARC offers an Expertise Transfer Fellowships to enable an established investigator to spend six to twelve months in an appropriate host institute in a low/medium-resource country in order to transfer knowledge and expertise in a research area relevant for the host country and related to the Agency's programmes.
    • The major areas of activity are focused on understanding cancer aetiology (including infections, nutrition, lifestyle, environment, radiation, genetics), developing strategies for cancer prevention (primary prevention, screening and implementation research) and elucidating the underlying mechanisms of carcinogenesis through studies of molecular and cell biology, molecular genetics, epigenetics and molecular pathology.
  • Senior Visiting Scientist Award
    • This Award is for qualified and experienced senior investigators with recent publications in international peer-reviewed scientific journals who wish to spend from six to twelve months at the IARC working on a collaborative project in a research area related to the Agency's programmes.
    • The major areas of activity are focused on understanding cancer aetiology (including infections, nutrition, lifestyle, environment, radiation, genetics), developing strategies for cancer prevention (primary prevention, screening and implementation research) and elucidating the underlying mechanisms of carcinogenesis through studies of molecular and cell biology, molecular genetics, epigenetics and molecular pathology.

Please visit the IARC website for further information on these schemes and others.